Last Price
0.91
Today's Change
+0.007 (0.77%)
Day's Change
0.904 - 0.98
Trading Volume
157,453
Market Cap
1 Million
Shares Outstanding
1 Million
Avg Volume
2,208,753
Avg Price (50 Days)
1.35
Avg Price (200 Days)
5.16
PE Ratio
-0.03
EPS
-35.21
Earnings Announcement
07-Nov-2024
Previous Close
0.90
Open
0.95
Day's Range
0.904 - 0.98
Year Range
0.81 - 25.26
Trading Volume
159,493
1 Day Change
1.88%
5 Day Change
3.65%
1 Month Change
-0.35%
3 Month Change
-59.29%
6 Month Change
-70.51%
Ytd Change
-93.99%
1 Year Change
-96.02%
3 Year Change
-99.99%
5 Year Change
-99.99%
10 Year Change
-99.99%
Max Change
-99.99%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.